Babesiosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

 Breaking News
  • No posts were found

Babesiosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

February 24
00:10 2023
Babesiosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
Delveinsight Business Research LLP
DelveInsight’s “Babesiosis- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Babesiosis, historical and forecasted epidemiology as well as the Babesiosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Babesiosis- Market Insights, Epidemiology, and Market Forecast-2032″  report delivers an in-depth understanding of the Babesiosis, historical and forecasted epidemiology as well as the Babesiosis market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The Babesiosis market report provides current treatment practices, emerging drugs, Babesiosis market share of the individual therapies, and current and forecasted Babesiosis market size from 2019 to 2032 segmented by seven major markets. The Report also covers current Babesiosis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities. It assesses the underlying potential of the market.

 Babesiosis Key Facts 

Individuals of any age can harbor parasites, and the burden of disease pathology is associated with age, with severe symptoms presenting in neonates, usually due to congenitally-transmitted infection, or to older adults, possibly due to depressed cellular immunity inhibiting the ability to prevent mild infections developing into severe disease. Further, individuals of any age that are immunocompromised, particularly those who are asplenic, are at greater risk of presenting with severe, acute disease, compared to healthy immune-competent individuals.

 Babesiosis Overview

Babesiosis is an infectious disease caused by protozoa of the genus Babesia that infect and lyse red blood cells. Babesia spp is transmitted primarily by tick vectors after their acquisition from small mammal reservoir hosts. Transmission occasionally occurs through blood transfusion and rarely through organ transplantation or congenitally. Babesia protozoa infect mammals and cause lysis of host red blood cells. Babesiosis is caused by microscopic parasites that infect red blood cells. Most human cases of Babesia infection in the United States are caused by the parasite Babesia microti. Occasional cases caused by other species (types) of Babesia have been detected. Babesia microti is spread in nature by Ixodes scapularis ticks (also called black-legged ticks or deer ticks). Tickborne transmission is most common in particular regions and seasons: it mainly occurs in parts of the Northeast and upper Midwest, and it usually peaks during the warm months. Babesia infection can range in severity from asymptomatic to life-threatening. The infection is both treatable and preventable.

 Babesiosis Epidemiology Insights: 

  • The main way is through the bite of an infected tick—during outdoor activities in areas where babesiosis is found (see below).

  • A less common way is by getting a transfusion from a blood donor who has a Babesia infection but does not have any symptoms. (No tests have been licensed yet for screening blood donors for Babesia.)

  • Rare cases of congenital transmission—from an infected mother to her baby (during pregnancy or delivery)—have been reported.

  • Babesia parasites are not transmitted from person to person like the flu or the common cold.

Babesiosis Epidemiology Segmentation

  • Babesiosis prevalent cases.

  • Babesiosis incident cases 

  • Babesiosis diagnosed cases 

  • Babesiosis treatment cases 

Babesiosis Market Outlook 

The Babesiosis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Babesiosis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Babesiosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

Learn more by requesting for sample @ Babesiosis Market Trends

Babesiosis Key Companies

Inmugen 

Table of Contents

  1.  Key Insights 

  2.  Report Introduction 

  1.  Executive Summary of Babesiosis    

  2.  Disease Background and Overview

  3.  Epidemiology and patient population

  4.  Babesiosis Emerging Therapies

  5.  Babesiosis Market Outlook

  6.  Market Access and Reimbursement of Therapies

  7.  Market Drivers 

  8.  Market Barriers 

  9.  Appendix

  10.  Babesiosis Report Methodology

  11.  DelveInsight Capabilities

  12.  Disclaimer

Click here to read more about Babesiosis Market Trends

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com

Categories